Clinical Genetics · Cleveland, OH
NPI
1316141492
Since 2007
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (216) 844-1000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.9M
64 prescriptions
Company payments, 2025
$13K
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Laura L Konczal prescribed most often to Medicare patients was Sapropterin Dihydrochloride, with 24 prescriptions and refills. In total Laura L Konczal wrote 64 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sapropterin Dihydrochloride Generic | 24 | 24 | Under 11 | $186K |
| Ravicti Glycerol Phenylbutyrate | 13 | 13 | Under 11 | $1.5M |
| Miglustat Generic | 12 | 12 | Under 11 | $137K |
Brand drugs: 17 claims; generic drugs: 47 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura L Konczal $13K ($13K in general payments such as food, travel and fees) from 4 companies. The largest payer was Ultragenyx Pharmaceutical Inc. with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.